Tailored Antiplatelet Therapy During Percutaneous Coronary Intervention in Patients With Diabetes Mellitus
A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 130 participants.
Also called NCT01475552
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; single masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 130 participants
- Registry
-
NCT01475552
-
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- South Korea
- Registry status
- Completed
Technical summary
Registry record NCT01475552. Randomized; single masking; primary purpose treatment. Start 2010-09 (registry gives no type); primary completion 2011-09 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Tailored Antiplatelet Therapy During Percutaneous Coronary Intervention in Patients With Diabetes Mellitus
- Condition
- Diabetes Mellitus
- Intervention (Drug)
- Abciximab
- Intervention (Drug)
- control
- Lead sponsor
- Seoul National University Bundang Hospital
Record details
- Record id
cardio:ct-nct01475552- Content hash
d9eb963c5418e530ad0c22575401403e1fcc146213b982bd8df0cfa933ca348c